First Time Loading...

Ergo Science Corp
OTC:ERGN

Watchlist Manager
Ergo Science Corp Logo
Ergo Science Corp
OTC:ERGN
Watchlist
Price: 10 800 USD
Updated: Apr 29, 2024

Balance Sheet

Balance Sheet Decomposition
Ergo Science Corp

Current Assets 10.9m
Cash & Short-Term Investments 3.5m
Other Current Assets 7.4m
Non-Current Assets 17.2m
PP&E 4.3m
Intangibles 4.3m
Other Non-Current Assets 8.5m
Current Liabilities 10.8m
Other Current Liabilities 10.8m

Balance Sheet
Ergo Science Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-1997 Dec-1998 Dec-1999 Dec-2000 Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006
Assets
Cash & Cash Equivalents
14
16
4
10
26
25
27
2
7
5
Cash Equivalents
14
16
4
10
26
25
27
2
7
5
Short-Term Investments
10
18
18
17
0
0
0
0
0
0
Total Receivables
0
0
0
0
0
0
0
7
5
0
Accounts Receivables
0
0
0
0
0
0
0
7
5
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
1
0
0
Other Current Assets
0
1
0
0
0
0
0
2
1
5
Total Current Assets
24
34
22
27
26
25
27
11
14
9
PP&E Net
2
0
0
0
0
0
0
4
4
4
PP&E Gross
2
0
0
0
0
0
0
4
4
0
Accumulated Depreciation
4
6
0
0
0
0
0
3
0
0
Intangible Assets
0
0
0
0
0
0
0
7
7
5
Long-Term Investments
0
0
8
0
0
0
0
0
0
0
Other Long-Term Assets
3
0
0
0
0
0
0
0
0
0
Other Assets
0
0
0
0
0
0
0
16
8
8
Total Assets
29
N/A
35
+21%
30
-12%
27
-11%
26
-5%
25
-3%
27
+8%
90
+232%
32
-64%
26
-18%
Liabilities
Accounts Payable
3
4
5
1
0
0
0
4
2
0
Accrued Liabilities
0
0
0
0
1
1
0
3
4
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
7
5
8
Total Current Liabilities
3
5
5
1
1
1
0
14
11
8
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
32
0
0
Total Liabilities
4
N/A
5
+39%
5
-6%
1
-79%
1
-5%
1
-26%
0
-47%
46
+12 523%
11
-77%
8
-24%
Equity
Common Stock
5
6
6
7
0
0
0
0
0
0
Retained Earnings
78
84
88
88
89
90
85
0
88
94
Additional Paid In Capital
101
112
112
112
112
112
112
0
112
112
Other Equity
4
4
4
5
2
2
2
43
4
2
Total Equity
25
N/A
30
+19%
26
-14%
26
+1%
25
-5%
24
-2%
27
+10%
43
+63%
21
-51%
18
-15%
Total Liabilities & Equity
29
N/A
35
+21%
30
-12%
27
-11%
26
-5%
25
-3%
27
+8%
90
+232%
32
-64%
26
-18%
Shares Outstanding
Common Shares Outstanding
0
0
0
0
0
0
0
0
0
0
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0

See Also

Discover More